Fifth Third Bancorp’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-100
| Closed | – | – | 2400 |
|
|
2019
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 2421 |
|
|
2019
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 2450 |
|
|
2019
Q2 | $0 | Buy |
+100
| New | +$50 | ﹤0.01% | 2435 |
|
|
2018
Q2 | – | Sell |
-128
| Closed | – | – | 2456 |
|
|
2018
Q1 | $0 | Hold |
128
| – | – | ﹤0.01% | 2508 |
|
|
2017
Q4 | $0 | Hold |
128
| – | – | ﹤0.01% | 2445 |
|
|
2017
Q3 | $0 | Hold |
128
| – | – | ﹤0.01% | 2393 |
|
|
2017
Q2 | $0 | Hold |
128
| – | – | ﹤0.01% | 2361 |
|
|
2017
Q1 | $0 | Hold |
128
| – | – | ﹤0.01% | 2327 |
|
|
2016
Q4 | $0 | Sell |
128
-235
| -65% | -$80 | ﹤0.01% | 2412 |
|
|
2016
Q3 | $0 | Hold |
363
| – | – | ﹤0.01% | 2434 |
|
|
2016
Q2 | $0 | Hold |
363
| – | – | ﹤0.01% | 2476 |
|
|
2016
Q1 | $0 | Hold |
363
| – | – | ﹤0.01% | 2991 |
|
|
2015
Q4 | $0 | Sell |
363
-410
| -53% | -$58 | ﹤0.01% | 3095 |
|
|
2015
Q3 | $0 | Hold |
773
| – | – | ﹤0.01% | 3186 |
|
|
2015
Q2 | $1K | Hold |
773
| – | – | ﹤0.01% | 2863 |
|
|
2015
Q1 | $1K | Hold |
773
| – | – | ﹤0.01% | 2773 |
|
|
2014
Q4 | $1K | Hold |
773
| – | – | ﹤0.01% | 2353 |
|
|
2014
Q3 | $0 | Hold |
773
| – | – | ﹤0.01% | 2607 |
|
|
2014
Q2 | $0 | Hold |
773
| – | – | ﹤0.01% | 2592 |
|
|
2014
Q1 | $0 | Hold |
773
| – | – | ﹤0.01% | 2467 |
|
|
2013
Q4 | $0 | Hold |
773
| – | – | ﹤0.01% | 2374 |
|
|
2013
Q3 | $2K | Hold |
773
| – | – | ﹤0.01% | 2152 |
|
|
2013
Q2 | $1K | Buy |
+773
| New | +$1.36K | ﹤0.01% | 2180 |
|
Fifth Third Bancorp's GCVRZ Position: Q1 2020 in Review
Fifth Third Bancorp sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 100 shares.
Fifth Third Bancorp first reported a position in GCVRZ in Q2 2013 and held it in 23 quarters. The position peaked at $2K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Fifth Third Bancorp reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Fifth Third Bancorp sold 100 Sanofi Contingent Value Rights shares in Q1 2020.
- Fifth Third Bancorp first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 23 quarters.
- Fifth Third Bancorp's Sanofi Contingent Value Rights position peaked at $2K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Fifth Third Bancorp's 13F filing for Q1 2020, filed 5 May 2020.